You can buy or sell BCTX and other stocks, options, and ETFs commission-free!
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
William V. Williams
West Vancouver, British Columbia
52 Week High
52 Week Low
— per share
Expected Jun 15, Pre-Market